While no official human dosing guidelines exist, anecdotal use and rodent-to-human conversions help shape general best practices
Dat is wat medische zorg is
You will see marketing that implies small, steady doses preserve lean mass
Our integrated approach has led to more than 96% of Oshi patients on GLP-1s reporting improvement and control over their symptoms within six months of starting care, which led to better reported quality of life and increased medication adherence
GLP-1 medicines are not approved for managing period, hot-flash, or energy symptoms, and a changed period, new hot flashes, or persistent fatigue should be discussed with your doctor or licensed clinician especially if symptoms are severe, sudden, or could indicate pregnancy or another condition